You Position: Home > Paper

A MARKER AS MINIMAL RESIDUAL DISEASE WITH BCR/ABL mRNA IN ACUTE LYMPHOBLASTIC LEUKEMIA

( views:229, downloads:0 )
Author:
No author available
Journal Title:
JOURNAL OF LEUKEMIA & LYMPHOMA
Issue:
3
DOI:
10.3760/cma.j.issn.1009-9921.2001.03.005
Key Word:
白血病淋巴细胞性,急性;聚合酶链反应;微小残留病

Abstract: 目的:检测急性淋巴细胞白血病(ALL)完全缓解后微小残留病(MRD),探讨其临床意义.方法:应用反转录-巢式聚合酶链反应(nest-PCR)检测ALL完全缓解后bcr/abl mRNA.结果:23例ALL患者中阳性5例,5例阳性者2月~13月内复发;而MRD阴性的18例中2例于缓解后2月、4月复发,余16例无复发.结论:ALL治疗完全缓解(CR)后仍存在MRD者有较高的复发危险,应进行巩固治疗和定期监测;MRD阴性可以做为临床疗效观察的客观指标.该方法检测MRD敏感度高,适用于临床.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn